18
Views
19
CrossRef citations to date
0
Altmetric
SECTION IV: PERSPECTIVES ON HEROIN TREATMENT PHILOSOPHIES WITH EMPHASIS ON METHADONE

Blind Dosage Comparisons and Other Studies in a Large Methadone Program

Pages 177-181 | Published online: 13 Jan 2012

REFERENCES

  • Goldstein , A. Blind Controlled Dosage Comparisons in Two Hundred Patients . Proceedings of Third National Conference on Methadone Treatment . pp. 31 – 37 . Washington , DC. : Government Printing Office. . PHS Publication No. 2172
  • Dole , V. P. and Nyswander , M. 1965 . “A Medical Treatment for Diacetylmorphine (Heroin) Addiction.” . J.A.M.A. , Vol. 193 23 August : 646 – 650 .
  • Dole , V. P. , Nyswander , M. and Warner , A. 1968 . “Successful Treatment of 750 Criminal Addicts.” . J.A.M.A. , Vol. 206 16 December : 2708 – 2711 .
  • Goldstein , A. and Brown , B. W. 1970 . “Urine Testing Schedules in Methadone Maintenance Treatment of Heroin Addiction.” . J.A.M.A. , Vol. 214 12 October : 311 – 315 .
  • Dole , V. P. and Nyswander , M. E. 1967 . “Heroin Addiction-A Metabolic Disease.” . Arch. Intern. Med. , Vol. 120 : 19 – 24 .
  • Dole , V. P. , Nyswander , M. E. and Kreek , M. J. 1966 . “Narcotic-Blockade.” . Arch. Intern. Med. , Vol. 118 : 304 – 309 .
  • Wikler , A. 1965 . “Conditioning Factors in Opiate Addiction and Relapse.”. ” . In Narcotics. Edited by: Wilner , D. M. and Kassebaum , G. G. 85 – 100 . New York : McGraw-Hill. .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.